Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Schering-Plough
Information provided by (Responsible Party):
Mark Kieran, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00916747
First received: June 5, 2009
Last updated: December 22, 2015
Last verified: December 2015